EMD-44727

Single-particle
3.73 Å
EMD-44727
3D View Gallery
Deposition: 02/05/2024
Map released: 27/08/2025
Last modified: 29/10/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-44727

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9bng summary report (pdf.gz) Map-9bng FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

SARS-CoV-2 spike HexaPro protein in complex with T18A trimeric antagonist

EMD-44727

Single-particle
3.73 Å
EMD-44727
3D View Gallery
Deposition: 02/05/2024
Map released: 27/08/2025
Last modified: 29/10/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Sample: Complex of SARS-CoV-2 spike HexaPro protein with trimeric T18A antagonist
Fitted models: 9bng

Deposition Authors: Young T
Development of an ultrahigh affinity, trimeric ACE2 biologic as a universal SARS-CoV-2 antagonist.
Gonzales J , Young T , Choi H, Park M, Jewel Y, Fan C, Purohit R, Bjorkman PJ , Williams JC
(2025) Commun Biol , 8 , 1428 - 1428
PUBMED: 41053501
DOI: doi:10.1038/s42003-025-08819-w
ISSN: 2399-3642
Grant Support: